Skip to main content
Clinical Trials/ACTRN12614000891628
ACTRN12614000891628
Completed
Phase 2

Acute randomised, double blind, placebo controlled crossover dietary intervention trial. A dose response evaluation of resveratrol supplementation on cerebrovascular function, mood and cognitive performance in type 2 diabetes mellitus.

Dementia Collaborative Research Centre0 sites40 target enrollmentAugust 21, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes
Sponsor
Dementia Collaborative Research Centre
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 21, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dementia Collaborative Research Centre

Eligibility Criteria

Inclusion Criteria

  • Non\-insulin\-dependent type 2 diabetes mellitus adults; non\-smoking; women must be postmenopausal; dementia\-free, Clinic SBP between 130\-160mmHg ; BMI less than 40kg/m2; computer literate; have measurable ultrasound signal on both sides of the head; unlikely to change medication/supplements during the intervention.

Exclusion Criteria

  • Suspected dementia (3MS score of less than 78/100 determined at screening); Smokers or currently on nicotine therapy; Neurological conditions; Kidney/liver disease; Insulin therapy ; Major depression as diagnosed by a health care professional; Visual problems including the inability to distinguish the colours of red, green, blue and yellow; Illiterate; Physical difficulty in both hands that will impede on motor performance of the hand/arm; Unable to obtain a measurable signal in the MCA; Unwilling to provide two blood samples at each visit; Unwilling to maintain pre\-enrolment physical activity levels and dietary habits for the duration of the trial.; Unwilling to fast for 4hr; Currently consuming resveratrol or other grape extract supplements.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Double-blind, randomised, placebo-controlled trial of nicotine replacement therapy in pregnancy - Smoking, Nicotine and Pregnancy (SNAP) TrialSmoking during pregnancy Specifically smoking 5 or more cigarettes currently (i.e. whilst pregnant) and having smoked 10 or more cigarettes prior to pregnancy.
EUCTR2004-002621-46-GBniversity of Nottingham1,050
Active, not recruiting
Phase 1
Clinical trial to assess the analgesic efficacy and the safety of an oral ibuprofen (arginine)-tramadol HCI combination administered to patients with moderate to severe pain after undergoing a dental surgery
EUCTR2020-005530-15-ESFarmalíder S.A.346
Active, not recruiting
Not Applicable
Randomised, placebo-controlled, double-blind, parallel-group, comparative study of two topical products for the treatment of psoriasismild to moderate plaque psoriasis
EUCTR2009-012855-90-CZJelfa SA
Active, not recruiting
Not Applicable
Double-blind, placebo-controlled, randomised, parallel-groups, multi-centre clinical trial for the evaluation of efficacy and safety of an ointment of comfrey extract in comparison to placebo in the treatment of acute upper or low back pai
EUCTR2006-003621-87-DEMerck Selbstmedikation GmbH
Recruiting
Not Applicable
Study to Investigate the Effects of Coenzyme Q10 Supplementation on Cardiovascular Health in Males Receiving Statin Medication for High Cholesterol LevelsDyslipidemiaMetabolic and Endocrine - Metabolic disordersCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
ACTRN12609000232235ipid and Diabetes Research Group30